The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events
Article
Mindlen, F, Nordaby, R, Ruiz, M et al. (1996). The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events
. Canadian Journal of Cardiology, 12(2), 127-137.
Mindlen, F, Nordaby, R, Ruiz, M et al. (1996). The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events
. Canadian Journal of Cardiology, 12(2), 127-137.